相似文献
1
Tuberculosis drug development: ensuring people living with HIV are not left behind.
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1107-13. doi: 10.1164/rccm.201106-0995PP. Epub 2011 Aug 25.
2
A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Afr J Prim Health Care Fam Med. 2018 Nov 15;10(1):e1-e5. doi: 10.4102/phcfm.v10i1.1765.
3
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Int J Infect Dis. 2017 Mar;56:39-44. doi: 10.1016/j.ijid.2017.01.023. Epub 2017 Feb 1.
4
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.
Curr HIV/AIDS Rep. 2020 Dec;17(6):589-600. doi: 10.1007/s11904-020-00529-8.
5
Antiretroviral Therapy in HIV-Infected Children With Tuberculosis: A Systematic Review.
Pediatr Infect Dis J. 2018 May;37(5):e117-e125. doi: 10.1097/INF.0000000000001784.
6
Tuberculosis and HIV Coinfection.
Cold Spring Harb Perspect Med. 2015 Feb 26;5(7):a017871. doi: 10.1101/cshperspect.a017871.
7
Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho.
Am J Trop Med Hyg. 2013 Jul;89(1):174-7. doi: 10.4269/ajtmh.13-0046. Epub 2013 May 13.
8
British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.
HIV Med. 2011 Oct;12(9):517-24. doi: 10.1111/j.1468-1293.2011.00954.x.
9
Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006418. doi: 10.1002/14651858.CD006418.pub2.
10
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.00420-17. Print 2018 Feb.
引用本文的文献
1
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
PLoS Med. 2019 Aug 15;16(8):e1002882. doi: 10.1371/journal.pmed.1002882. eCollection 2019 Aug.
2
Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
PLoS One. 2012;7(11):e47370. doi: 10.1371/journal.pone.0047370. Epub 2012 Nov 5.
3
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1.
本文引用的文献
1
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
Clin Infect Dis. 2011 Jun;52(11):1374-83. doi: 10.1093/cid/cir230.
2
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.
3
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14.
4
Treatment 2.0: catalysing the next phase of scale-up.
Lancet. 2011 Jul 16;378(9787):209-11. doi: 10.1016/S0140-6736(11)60247-X. Epub 2011 Feb 25.
5
TB and HIV integration: obstacles and possible solutions to implementation in South Africa.
Trop Med Int Health. 2011 Apr;16(4):431-8. doi: 10.1111/j.1365-3156.2010.02721.x. Epub 2011 Jan 24.
6
Paradoxically elevated efavirenz concentrations in HIV/tuberculosis-coinfected patients with CYP2B6 516TT genotype on rifampin-containing antituberculous therapy.
AIDS. 2011 Jan 28;25(3):388-90. doi: 10.1097/QAD.0b013e3283427e05.
7
Drugs in development for tuberculosis.
Drugs. 2010 Dec 3;70(17):2201-14. doi: 10.2165/11538170-000000000-00000.
8
Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.
AIDS. 2011 Jan 2;25(1):49-55. doi: 10.1097/QAD.0b013e32833f9e04.
9
Rapid molecular detection of tuberculosis and rifampin resistance.
N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.
10
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.
Lancet. 2010 Jul 31;376(9738):367-87. doi: 10.1016/S0140-6736(10)60829-X.
Zotero 插件